Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis
Status:
Completed
Trial end date:
2021-07-18
Target enrollment:
Participant gender:
Summary
This will be a randomised, double-blind, placebo-controlled, proof-of-mechanism phase 2 trial
investigating the effect of quinagolide extended-release vaginal ring on reduction of lesions
assessed by high-resolution magnetic resonance imaging in women with endometrioma, deep
infiltrating endometriosis, and/or adenomyosis.